152606-17-2 Usage
General Description
3-Amino-3-(2,4-Dichloro-phenyl)-Propionic Acid is a specialized chemical compound known for its distinct structural formula. The presence of both amino and carboxylic acid functional groups in its structure may suggest that it participates in various chemical reactions, possibly including interactions with biological systems. The 2,4-Dichloro-phenyl component indicates the presence of a phenyl ring - a functional group that often contributes to the stability of the compound, and is substituted with two chlorine atoms. These halogens may further influence the compound's reactivity and interactions. However, specific information regarding its properties and uses may be largely dependent on the broader context of its application, which could range from research to manufacturing, or its role as an intermediate compound in the synthesis of more complex chemical structures.
Check Digit Verification of cas no
The CAS Registry Mumber 152606-17-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,2,6,0 and 6 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 152606-17:
(8*1)+(7*5)+(6*2)+(5*6)+(4*0)+(3*6)+(2*1)+(1*7)=112
112 % 10 = 2
So 152606-17-2 is a valid CAS Registry Number.
InChI:InChI=1/C9H9Cl2NO2/c10-5-1-2-6(7(11)3-5)8(12)4-9(13)14/h1-3,8H,4,12H2,(H,13,14)
152606-17-2Relevant articles and documents
Preparation and application of novel eEF2K depressant
-
Paragraph 0043-0047; 0050, (2018/05/01)
The invention relates to preparation and application of an eEF2K depressant and belongs to the technical field of antitumor pharmacy. A technical problem to be solved by the invention is to provide acompound as the eEF2K depressant. The compound comprises a compound represented by a formula shown in the description or pharmaceutically acceptable salts thereof. The compound or pharmaceutically acceptable salts thereof can serve as the eEF2K depressant, have certain anti-tumor activity and can effectively depress the growth of cancer cells. The compound disclosed by the invention has an obviousdepression action on a variety of tumor cells, particularly three-negative mammary cancer cells.
